Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
A SPAC I Acquisition Unit | ASCAU | Apr 26, 2024 | 2.96 | 0.00 |
A SPAC II Acquisition | ASCB | Apr 26, 2024 | 11.14 | +0.54 |
A-Mark Precious Metals | AMRK | Apr 26, 2024 | 40.12 | +4.10 |
a.k.a Brands | AKA | Apr 26, 2024 | 12.75 | +1.03 |
A.O Smith | AOS | Apr 26, 2024 | 83.21 | +0.47 |
A10 Networks | ATEN | Apr 26, 2024 | 13.54 | -0.29 |
A2Z Smart Technologies | AZ | Apr 26, 2024 | 0.39 | -3.69 |
AAA - A Rated Corporate Bond Ishares | QLTA | Apr 26, 2024 | 46.13 | +0.22 |
Aadi Bioscience | AADI | Apr 26, 2024 | 1.75 | +4.17 |
AAON | AAON | Apr 26, 2024 | 91.15 | +1.39 |
AAR | AIR | Apr 26, 2024 | 68.27 | +1.26 |
Abacus Life | ABL | Apr 26, 2024 | 11.93 | -0.42 |
Abbott Laboratories | ABT | Apr 26, 2024 | 107.53 | +0.63 |
AbbVie | ABBV | Apr 26, 2024 | 159.62 | -4.58 |
AbCellera Biologics | ABCL | Apr 26, 2024 | 3.76 | +3.58 |
Abeona Therapeutics | ABEO | Apr 26, 2024 | 3.26 | +2.19 |
Abercrombie & Fitch | ANF | Apr 26, 2024 | 122.08 | +5.74 |
Aberdeen Asia-Pacificome Fund | FAX | Apr 26, 2024 | 2.57 | +1.98 |
Aberdeen Australia Equity Fund | IAF | Apr 26, 2024 | 4.22 | -0.47 |
Aberdeen Emerging Markets Fund | AEF | Apr 26, 2024 | 5.04 | +1.72 |
Aberdeen Global Fund | FCO | Apr 26, 2024 | 5.57 | +1.83 |
Aberdeen Global Infrastructure | ASGI | Apr 26, 2024 | 17.21 | -0.69 |
Aberdeen Income Credit Strategies Fund | ACP | Apr 26, 2024 | 6.52 | +0.93 |
Aberdeen Income Credit Strategies Pref | ACP-A | Apr 26, 2024 | 24.35 | +1.29 |
Aberdeen Japan Equity Fund | JEQ | Apr 26, 2024 | 5.85 | +0.69 |
Abits Group | ABTS | Apr 26, 2024 | 0.79 | +7.86 |
Abivax SA - American Depositary Shares | ABVX | Apr 26, 2024 | 15.78 | +0.25 |
Able View Global | ABLV | Apr 26, 2024 | 1.59 | -4.79 |
ABM Industries | ABM | Apr 26, 2024 | 44.04 | -0.65 |
Abrdn Global Dynamic Dividend Fund | AGD | Apr 26, 2024 | 9.42 | +1.29 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.